Search for: "IN RE TALIS BIOMEDICAL SECURITIES LITIGATION" Results 1 - 1 of 1
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Gibson Dunn Offers 2022 Year-End Securities Litigation Update
27 Mar 2023, 9:01 pm by renholding
We examine developments in federal securities litigation involving special purpose acquisition companies. [read post]
The CLS Blue Sky Blog - https://clsbluesky.law.columbia.edu/